RMD - ResMed Total Debt to Capital

ResMed Corp (RMD) - corporate logo

Steady demand for apnea therapy equipment provides ResMed Inc. (RMD) with a reliable stream of liquidity. The capital structure ratio (total debt to equity) reflects the leverage trend, with the current mark standing at 0.12. However, geopolitical tensions are complicating electronics logistics and exports. Simultaneously, the company is implementing biodegradable packaging and eco-design to minimize environmental impact.

RMD: resmed.com Total Debt to Equity Ratio 07/04/2022 - 10/29/2026
Finished products of ResMed Inc.

Assessing the operational strength of assets begins with an analysis of the business's financing structure. For ResMed Inc., which maintains its status as a technological leader in sleep therapy, the balance between investments and loans is critical. The dynamics of the debt-to-equity ratio reflect the proportion of liabilities relative to shareholders' equity. An increase in this metric signals elevated default risks during a downturn, while a low level of leverage confirms the fundamental stability of the company.

Competitor analysis

Debt to Equity Boston Scientific Corporation|Edwards - Aggregate Debt to Equity|Total Debt to Capital PODD|ZBH - Debt to Capital|Total Debt to Capital COO (The Cooper Companies)|ALGN - Total Debt to Equity Ratio|Globus Medical - Total Debt to Capital|Total Debt to Capital Coefficient transmedics.com TMDX|ATEC: Total Debt to Capital|Artivion Corp (AORT) - Total Debt to Capital|Debt to Equity Enovis Corporation|Debt to Equity IART|Total Debt to Capital ESTA|Total Debt to Capital Coefficient Beta Bionics, Inc.|Iradimed - Total Debt to Equity Ratio|EMBC (Embecta Health) - Aggregate Debt to Equity|Tandem Diabetes Care - Total Debt to Capital|Debt to Capital axogeninc.com|SIBN: Total Debt to Capital|Debt to Equity Ratio OFIX|Total Debt to Equity Ratio BVS|KIDS: All Debt to Shareholders' Equity Ratio|Debt to Equity Treace Medical Concepts (TMCI)|Total Debt to Equity Ratio blade.com SRTA|Total Debt to Capital CARL (Carlsmed)|RxSight Inc (RXST) - Debt to Capital|ClearPoint - Total Debt to Capital|STXS (Stereotaxis Corporation) - Debt to Equity Ratio|STIM: Total Debt to Capital|SGHT - Total Debt to Capital Coefficient|OBIO (Orchestra BioMed, Inc.) - Total Debt to Capital|Total Debt to Equity Ratio Anika (ANIK)|Total Debt to Capital NSPR|Total Debt to Capital zhjmedical.com (ZJYL)|Debt to Equity Vivani Medical VANI|Xtant Medical Holdings, Inc. - Debt to Equity|NMTC: Total Debt to Equity Ratio|All Debt to Shareholders' Equity Ratio MODD (Modular Medical)|MYO: Total Debt to Capital|Debt to Capital Envoy Medical Inc (COCH)|Debt to Equity Vivos Therapeutics|NVNO - Debt to Capital Ratio|Total Debt to Equity Ratio SINT (Sintx Technologies)|Total Debt to Capital Tenon Medical Inc. (TNON)|Total Debt to Capital LFWD (ReWalk Robotics Ltd)|Total Debt to Capital Coefficient Autonomix Medical Inc. (AMIX)|IVF - Debt to Equity|Aggregate Debt to Equity BBLG|Axonics (AXNX) - Debt to Equity|Total Debt to Equity Ratio BIOLASE Inc.|DYNT (Dynatronics Corp) - Total Debt to Capital|Debt to Capital Paragon 28 Corp FNA|Debt to Equity INVO Bioscience, Inc. (INVO)